The B7 homolog 3 (CD276) is a transmembrane molecule expressed in several types of cancers where it functions as an immune checkpoint receptor, and it can be targeted efficiently by both CAR-T cells and mAb (237–241). The gene discussed is CD276; the disease is cancer.